Study on the Combined Treatment of Hepatocellular Carcinoma With Envafolimab, Suvemcitug and HAIC Conversion
Clinical trial NCT07738055 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07738055
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2029-01-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.